Literature DB >> 10513790

Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation.

F Marín1, V Roldán, J V Monmeneu, V Bodí, C Fernández, F G de Burgos, P Marco, F Sogorb.   

Abstract

Patients with mitral stenosis in sinus rhythm are in a prothrombotic state and have fibrinolytic dysfunction, shown by an increase in levels of the inhibitor of tissue plasminogen activator, D-dimer, and modified antithrombin III. This state may be observed even in patients without dilated left atria (diameter < or =45 mm).

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10513790     DOI： 10.1016/s0002-9149(99)00453-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  9 in total

1.  Impaired fibrinolysis in degenerative mitral and aortic valve stenosis.

Authors:  Piotr Mazur; Jacek Myć; Joanna Natorska; Krzysztof Plens; Dariusz Plicner; Grzegorz Grudzień; Bogusław Kapelak; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

Review 2.  Biomarkers in atrial fibrillation: investigating biologic plausibility, cause, and effect.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

3.  Plasma level of soluble P-selectin in patients with rheumatic mitral stenosis and sinus rhythm undergoing percutaneous mitral balloon valvuloplasty.

Authors:  Serkan Topaloglu; Dursun Aras; Kumral Ergun; Bilal Geyik; Selime Ayaz; Serkan Cay; Goksel Cagirci; Omac Tufekcioglu; Sule Korkmaz
Journal:  J Thromb Thrombolysis       Date:  2006-11-28       Impact factor: 2.300

4.  Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.

Authors:  F Marín; V Roldán; V E Climent; A Ibáñez; A García; P Marco; F Sogorb; G Y H Lip
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

5.  Impaired fibrinolytic capacity in rheumatic mitral stenosis with or without atrial fibrillation and nonrheumatic atrial fibrillation.

Authors:  Enver Atalar; Ferhan Ozmen; Ibrahim Haznedaroğlu; Necla Ozer; Serdar Aksöyek; Kenan Ovünç; Nasih Nazli; Serafettin Kirazli; Sirri Kes
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.

Authors:  Na Wu; Shifei Tong; Ying Xiang; Long Wu; Bin Xu; Yao Zhang; Xiangyu Ma; Yafei Li; Zhiyuan Song; Li Zhong
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 7.  Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review.

Authors:  Alexander Weymann; Anton Sabashnikov; Sadeq Ali-Hasan-Al-Saegh; Aron-Frederik Popov; Seyed Jalil Mirhosseini; William L Baker; Mohammadreza Lotfaliani; Tong Liu; Hamidreza Dehghan; Senol Yavuz; Michel Pompeu Barros de Oliveira Sá; Jae-Sik Jang; Mohamed Zeriouh; Lei Meng; Fabrizio D'Ascenzo; Abhishek J Deshmukh; Guiseppe Biondi-Zoccai; Pascal M Dohmen; Hugh Calkins; Integrated Meta-Analysis Of Cardiac Cardiac Surgery And Cardiology-Group Imcsc-Group
Journal:  Med Sci Monit Basic Res       Date:  2017-03-31

8.  Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.

Authors:  Guangbin Wang; Nini Rao; Dingyun Liu; Hongxiu Jiang; Ke Liu; Feng Yang; Yangwei Chen; Keli Huang
Journal:  PLoS One       Date:  2019-09-03       Impact factor: 3.240

9.  Atrial fibrillation alters the microRNA expression profiles of the left atria of patients with mitral stenosis.

Authors:  Hai Liu; Guang-Xian Chen; Meng-ya Liang; Han Qin; Jian Rong; Jian-ping Yao; Zhong-kai Wu
Journal:  BMC Cardiovasc Disord       Date:  2014-01-25       Impact factor: 2.298
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.